Design, synthesis, biological evaluation, and in silico studies of novel pyridopyridine derivatives as anticancer candidates targeting FMS kinase-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Design, synthesis, biological evaluation, and in silico studies of novel pyridopyridine derivatives as anticancer candidates targeting FMS kinase

Published:2024-08 Issue: Volume:274 Page:116557
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Sebastian Anusha,Abu Rabah Reinad R.,Zaraei Seyed-Omar,Vunnam Srinivasulu,Sultan Shaista,Anbar Hanan S.,El-Gamal Randa,Tarazi Hamadeh,Sarg Nadin,Alhamad Dima W.,Al Shamma Salma A.,Shahin Afnan I.,Omar Hany A.,Al-Tel Taleb H.,El-Gamal Mohammed I.^ORCID

Funder

National Cancer Institute

University of Sharjah

Publisher

Elsevier BV

Reference42 articles.

1. Small-molecule kinase inhibitors for the treatment of nononcologic diseases;Xie;J. Med. Chem.,2021

2. Kinase inhibitors: the road ahead;Ferguson;Nat. Rev. Drug Discov.,2018

3. Trends in kinase drug discovery: targets, indications and inhibitor design;Attwood;Nat. Rev. Drug Discov.,2021

4. Properties of FDA-approved small molecule protein kinase inhibitors: a 2023 update;Roskoski;Pharmacol. Res.,2023

5. Multi or single-kinase inhibitors to counteract drug resistance in cancer: what is new?;Pecoraro;Curr. Med. Chem.,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP